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Uterine cervical adenocarcinomas (C-ACs) are important
neoplasias in the female reproductive tract, along with squamous
cell carcinomas (SCCs). Several studies have demonstrated
possible associations between gene abnormalities and tumori-
genesis of SCCs (Park et al, 1994; Saegusa et al, 1995), but there
have been only a few reports regarding the molecular mechanisms
of development and progression of C-ACs.
Early studies of tumour suppressor genes indicated that their
gene products may be involved in preventing cellular prolifera-
tion, possibly directly through inhibiting DNA replication or indi-
rectly through regulating the transcription of other genes involved
in controlling the cell cycle (Ginsberg et al, 1991; Mercer et al,
1991). The DCC gene, located in the chromosome 18q21.3 band,
was originally identified as a tumour suppressor gene in colorectal
carcinomas (Fearon et al, 1990). Klingelhutz et al (1995) have
demonstrated that a full length DCC can inhibit tumorigenicity of
neoplastic cells lacking DCC expression. Recent studies have
revealed that DCC gene alterations are also involved in tumori-
genesis in a variety of other human malignancies (Huang et al,
1992; Uchino et al, 1992; Gao et al, 1993). Although frequent loss
or reduction of DCC expression has been reported in endometrial
and ovarian carcinomas (Gima et al, 1994; Enomoto et al, 1995),
alteration of this gene in their AC counterparts in the cervix has
not been described in detail.
Analysis of tissue kinetics, including cell deletion (apoptosis)
and proliferation, provides information on the mechanisms of
tumour progression, since loss of tissue homeostasis is closely
linked to tumour growth patterns. Recently, multiple cyclins and
cyclin-dependent kinases (CDKs) as positive cell cycle regulators
and specific inhibitory proteins (CDIs), including p21WAF1/Cip1,
p27Kip1, p16MTS1 and p15MTS2, have been identified in mammalian
cells. CDIs have been proposed as candidate tumour suppressor
genes, since their overexpression is associated with G1 arrest (El-
Deiry et al, 1993; Serrano et al, 1993; Harper et al, 1993; Hannon
and Beach, 1994; Kamb et al, 1994; Nobori et al, 1994; Polyak
et al, 1994; Toyoshima and Hunter, 1994).
In the present study, we immunohistochemically investigated
normal and malignant cervical glandular components to clarify the
relation of DCC expression to tumour differentiation and cell
kinetics. In addition, a combination of the reverse transcription-
polymerase chain reaction (RT-PCR) and Southern blot hybridiza-
tion (SBH), and Western blot assays were performed. Expression
of p21WAF1/Cip1 and p27Kip1, apoptosis, cell proliferation and human
papillomavirus (HPV) infection were selected as parameters for
comparison.
MATERIALS AND METHODS
Cases
A total of 80 cases of C-ACs, surgically resected at the Kitasato
University Hospital from 1985 to 1997, were investigated, along
with 39 samples of normal uterine cervix adjacent to carcinomas.
All tissues were routinely fixed in 10% formalin and embedded in
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were significantly higher in E-ACs than M-ACs, in line with high apoptotic, mitotic and Ki-67 labelling indices. A concordance of the results for
DCC and p21WAF1/Cip1 expression between mRNA- and protein-based assays was also noted. Change of DCC expression, however, was not
related to any of the cell kinetic markers or clinicopathological features in ACs of either type. There was also no association with the HPV
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Correspondence to: M Saegusaparaffin wax. Histological diagnosis was performed according to
the World Health Organization (WHO) classification. Carcinoma
cases comprised 31 endometrioid (E-AC, 17 grade (G) 1, and 14
G2 and G3), 31 mucinous (M-AC, 19 G1, and 12 G2 and G3), and
18 adenocarcinoma in situ (AIS) lesions. Of the 31 E-ACs, 20
were classified as FIGO (International Federation of Gynecology
and Obstetrics) stage I, 11 as stage II–IV, and eight were positive
for lymph node metastasis. Of the M-ACs, 20 were stage I and 11
stage II–IV, while nine were positive for lymph node metastasis.
Nine C-ACs (two M- and seven E-ACs) were snap-frozen in liquid
nitrogen for RT-PCR/SBH analysis of DCC and p21WAF1/Cip1
mRNAs, and Western blot assays for p21WAF1/Cip1 and p27Kip1
proteins.
Immunohistochemistry
Immunohistochemistry was performed using a combination of
the microwave oven heating and the standard streptavidin–
biotin–peroxidase complex (LSAB kit, Dako, Copenhagen,
Denmark) methods. Briefly, slides were heated in 10 mM citrate
buffer (pH 6.0) for six 5-min cycles for DCC and three 5-min
cycles for p21WAF1/Cip1, p27Kip1 and Ki-67 antigen, using a
microwave oven, and then incubated overnight at 4°C with
optimum dilutions of primary antibodies. The antibodies
employed were anti-human DCC monoclonal antibody (clone
G97-449, ´ 100 dilution; Pharmingen, San Diego, CA, USA),
anti-WAF1 monoclonal antibody for p21WAF1/Cip1 (´ 20 dilution,
Novocastra Laboratories Ltd., Newcastle, UK), anti-Kip1 mouse
monoclonal antibody for p27Kip1 (´ 1000 dilution; Transduction
Laboratories, Lexington, KY, USA), and rabbit anti-human Ki-67
antigen (´ 150 dilution; Dako). To confirm the specificity of
binding, normal mouse or rabbit sera (´ 500 dilution) were
supplied instead of primary antibodies as negative controls.
Scoring for immunoreactivity
Scoring of the immunohistochemistry results was made as previ-
ously reported (Saegusa et al, 1996). Briefly, based on the percent-
ages of immunopositive epithelial cells in the totals of normal or
neoplastic cells, subdivision for DCC and p27Kip1 was into five
categories as follows: 0, all negative; 1, < 10% positive cells;
2, 10–30%; 3, 30–50%; and 4, > 50%. Subclassification for
p21WAF1/Cip1 was as follows: 0, all negative; 1, < 5% positive cells;
2, 5–10%; 3, 10–30%; and 4, > 30%. The immunointensity was
also subclassified into four groups: 0, negative; 1+, weak; 2+,
moderate; and 3+, strong. Immunoreactivity scores were generated
by multiplication of the values for the two parameters. Normal
squamous or endocervical glandular epithelia adjacent to carci-
nomas in each case were used as positive controls for the three
antibodies.
Apoptotic and mitotic indices (AI and MI), and Ki-67
labelling index (LI)
Detection of apoptotic cells in haematoxylin and eosin stained
sections was performed, using high-power (´ 40 object and ´ 10
ocular) magnifications, in accordance with the criteria of Kerr et al
(1994). AI values were calculated after examining at least 2000
nuclei in five randomly selected fields for each case. Areas of
severe inflammatory cell infiltration and necrosis were excluded,
since some doubtful cells were observed in such regions. MI and
Ki-67 LI values were also calculated in a similar manner, counting
either mitotic figures or Ki-67-positive nuclei.
RT-PCR
Total cellular RNA was extracted from frozen tissues using Isogen
(Nippon Gene Co., Tokyo, Japan) in accordance with the manufac-
turer’s instructions. cDNA was synthesized from 5 mg of total
RNA using RAV-2 reverse transcriptase (Takara, Shiga, Japan) in
the presence of random primers (Takara) and a ribonuclease
inhibitor (Takara) in a 20 ml reaction volume at 42°C for 60 min.
One microlitre of cDNA solution was amplified by Taq poly-
merase (Takara) in a volume of 10 ml. For detection of DCC
mRNA expression in exons 6–7, sense and antisense primers used
were 5¢-TTCCGCCATGGTTTTTAAATCA-3¢, and 5¢-AGCCT-
CATTTTCAGCCACACA-3¢, corresponding to nucleotides
986–1007 and 1218–1198 respectively, in the cDNA sequences
published by Fearon et al (1990). Other primer sets within exon 17
described by Reale et al (1994) were also applied: DCK2834S,
5¢-CCCAGACTAACTGCATCATCATGAG-3¢ (sense), and
DCK3151A, 5¢-CACCTACTGGTGGGAGCAT-3¢ (anti-sense).
For amplification of p21WAF1/Cip1 mRNA, primers were 5¢-GCGC-
CATGTCAGAACCGGCTG-3¢ and 5¢-GCAGGCTTCCT-
GTGGGCGGAT-3¢, the products including the whole translated
region of this gene (Nadal et al, 1997). The PCR procedure was
performed with 35 cycles of denaturation at 94°C for 0.5 min.
annealing at 55°C for 1 min and extension at 72°C for 1 min, with
a final extension time of 7 min. As a negative control, water was
supplied instead of template DNA for each examination. To
examine the quality and quantity of the synthesized cDNA,
amplification with b-actin specific primers (sense, 5¢-TGC-
TATCCAGGCTGTGCTAT-3¢ and antisense, 5¢-GATGGAG-
TTGAAGGTAGTTT-3¢) was also carried out. PCR assays were
performed in duplicate or triplicate.
SBH
A 10 ml aliquot of each PCR reaction mixture was electrophoresed
in a 3.0% agarose gel and transferred to a Hybond N nylon
membrane (Amersham, Tokyo Japan) with 10 ´ saline–sodium
citrate (SSC) solution overnight. After prehybridization using DIG
Easy Hyb (Boehringer Mannheim, Tokyo, Japan) solution, filters
were hybridized overnight with each digoxigenin-labelled exon-
specific probe, which corresponded to internal sites between the
primer sets used. The sequences of oligonucleotide probes for
DCC exon 6/7, DCC exon 17, p21WAF1/Cip1 and b-actin were as
follows: probe DCC exon 6/7 (5¢-AATTGGATGAAGAATGGA-
GATGTGGTCATT-3¢, encoding nucleotides 1087–1116 in the
cDNA sequence), probe DCC exon 17 (5¢-ATGAGTTGGACTC-
CTCCCTTGAAC-3¢, nucleotides 2226–2250), probe p21WAF1/Cip1
(5¢-TGAGCGATGGAACTTCGACTTTGTCACCGA-3¢,
nucleotides 216–245), and probe b-actin (5¢-ACTGACTACCT-
CATGAAGATCCTCACCGAG-3¢, nucleotides 597–626).
Hybridization signals were detected with a DIG Luminescent
Detection Kit (Boehringer Mannheim). The conditions used for
hybridization, washing and detection were in line with the manu-
facturer’s recommendations. Between each hybridization the filter
was stripped before being rehybridized with another probe.
Quantitation of hybridization signals for DCC exons 6/7 and 17,
and b-actin, respectively, was performed by densitometric analysis
using NIH Image software, version 1.58. The relative expression
52 M Saegusa and I Okayasu
British Journal of Cancer (1999) 80(1/2), 51–58 © Cancer Research Campaign 1999level of DCC mRNA was calculated by normalization to the
hybridization signals for b-actin in each case.
Western blot assay
Tissue samples were homogenized in 0.1 M phosphate-buffered
saline (PBS) solution and clarified by centrifugation (12 000 rpm,
30 min). Fifty-microgram protein samples were separated by 12%
sodium dodecyl sulphate (SDS)-polyacrylamide gel electro-
phoresis and then electroblotted (50 mA for 2 h) onto immobilon-
P (Millipore, Tokyo, Japan). After blocking with Block
Ace (Dainihonseiyaku Co., Osaka, Japan), the membranes were
incubated overnight at 4°C with optimum dilutions of primary
anti-WAF1 (´ 20 dilution) and anti-Kip 1 (´ 1000 dilution) mouse
monoclonal antibodies. Reactivity was visualized using the
Western Blot Chemiluminescence Reagent (NENTM Life Science
Products, Boston, MA, USA). As positive controls, normal squa-
mous epithelium or squamous cell carcinomas (SCC) of uterine
cervix were used since a high frequency of p21WAF1/Cip1 expression
has been demonstrated for the latter (Nadal et al, 1997) and p27Kip1
immunopositivity is present in the former (Jordan et al, 1998).
HPV detection
DNA samples were extracted from several serial 10 mm thick
paraffin wax sections, through phenol–chloroform treatment.
Aliquots of DNA (100 ng) were used as templates in a reaction
volume of 10 ml containing 1 mM of each primer targeting the L1
open reading frame. The general primers used can detect eight
types of HPV (6, 11, 16, 18, 30, 32 and 33) (Toh et al, 1992). The
PCR assay entailed 40 cycles of 0.5 min at 94°C, 1 min at 40°C
and 1 min at 72°C. The quality of the DNAs was confirmed with
b-globin gene specific primers (Coates et al, 1991).
Statistics
Data for AI, MI, Ki-67 LI and immunoreactivity scores of several
markers were analysed using the Mann–Whitney U-test.
Correlations were examined using the Pearson’s correlation coeffi-
cient. The cut-off for statistical significance was defined as
P < 0.05.
RESULTS
DCC expression
Moderate to strong cytoplasmic immunoreactivity for DCC was
diffusely observed in endocervical glandular cells. The majority of
other cervical components, including stromal cells, vessels and
smooth muscular cells, lacked immunoreactivity (Figure 1A).
A variety of immunostaining patterns for DCC were found
in AIS and AC lesions. Some tumours showed a diffuse strong
cytoplasmic immunoreactivity, while others were negative or
demonstrated sporadic positivity. Stromal tissues within tumours
were consistently negative (Figure 1B,C).
The average values for DCC immunoreactivity scores were
significantly lower in E-ACs than normal glandular cells, but
similar values were found for normal, AIS and M-AC categories
(Figure 2). No correlations with other clinical or pathological
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Figure 1 DCC immunoreactivity in normal cervical glandular epithelium (A) and adenocarcinomas of mucinous (B) and endometrioid (C) types. Note the
moderate (A), strong (B) and weak (C) immunointensities; ´ 400parameters, including histological malignancy, FIGO stage and
lymph node status, were observed in ACs of either type (data not
shown).
p21WAF1/Cip1 and p27Kip1 expression
In normal cervical components, weak nuclear immunoreactivity
for p21WAF1/Cip1 was sporadically observed in a few glandular cells,
while most stromal tissue components lacked staining. In contrast,
moderate to strong immunopositivity for p27Kip1 with distinct
nuclear staining was occasionally found in epithelial and stromal
elements, including infiltrating lymphocytes.
In AIS and ACs, clusters of p21WAF1/Cip1-positive cells with weak
to strong immunoreactivity were sporadically observed in tumour
lesions, showing marked heterogeneity (Figure 3A,C). On the
other hand, p27Kip1-positive cells were diffusely distributed in most
tumours (Figure 3B,D).
The average p21WAF1/Cip1 scores increased in the sequence
leading from normal cervical glandular cells to E-ACs, the differ-
ence being significant, while p27Kip1 scores in AIS and E-ACs,
respectively, were significantly higher than either normal or M-AC
values (Figure 2). There was no association between either
p21WAF1/Cip1 or p27Kip1 scores and any of the clinicopathological
factors investigated (data not shown).
AI, MI and Ki-67 LI
Detailed morphological features of apoptotic cells have been
reported previously (Saegusa et al, 1996; Koshida et al, 1997).
Cells undergoing apoptosis were more frequently identified in
tumour lesions, in particular AIS and E-ACs, than in normal glan-
dular epithelia. Similar findings for mitotic figures and nuclear Ki-
67 immunopositivity were also observed (Figure 4). The average
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Figure 2 Immunoreactivity scores for DCC, p21WAF1/Cip1 and p27Kip1.
N, normal cervical glandular epithelium; A, adenocarcinoma in situ;
M, mucinous type adenocarcinoma; E, endometrioid type adenocarcinoma.
The data are means ± s.d. values. a, P = 0.012; b, P = 0.027; c, P = 0.0053;
d, P = 0.0048; e, P = 0.012; f, P = 0.007; g, P = 0.0014
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Figure 3 Immunohistochemistry of p21WAF1/Cip1 (A, C) and p27Kip1 (B, D) in mucinous (A, B) and endometrioid (C, D) type cervical adenocarcinomas. Distinct
nuclear staining of these proteins is evident. (D) Note the immunopositivity of infiltrating lymphocytes (indicated by arrows); ´ 400DCC in cervical adenocarcinoma 55
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Figure 4 (A, C) Apoptotic (indicated by long arrows) and mitotic cells (indicated by short arrows) in mucinous (A) and endometrioid (C) type adenocarcinomas.
Apoptotic cells are characterized by overall shrinkage and homogeneously dark basophilic nuclei, presence of nuclear fragments (apoptotic bodies), sharply
delineated cell borders surrounded by empty space, and homogeneous eosinophilic cytoplasm; haematoxylin and eosin ´ 400. (B, D) Ki-67 immunoreactivity in
mucinous (B) and endometrioid (D) type adenocarcinomas; ´ 200
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Figure 5 (A) Apoptotic and mitotic indices (Al and Ml); a, P = 0.01; b, P = 0.04; c, P = 0.026. (B) Ki-67 labelling index; d, P = 0.02. N, normal cervical
glandular epithelium; A, adenocarcinoma in situ; M, mucinous type adenocarcinoma; E, endometrioid type adenocarcinoma. The data are means ± s.d. values.
(C) Correlations among Al, Ml and Ki-67 LI for all samplesvalues of AI, as well as MI and Ki-67 LI values, were significantly
lower in M-ACs than either AIS or E-ACs respectively (Figure
5A,B) Positive correlations among AI, MI and Ki-67 LI in normal
and malignant lesions were noted (Figure 5C).
Correlations among DCC, p21WAF1/Cip1, p27Kip1, apoptosis
and cell proliferation
DCC scores was not correlated with values for p21WAF1/Cip1 and
p27Kip1 in any category of cervical lesion. Furthermore, no associ-
ation with AI, MI and Ki-67 LI was apparent (data not shown). By
contrast, p21WAF1/Cip1 and p27Kip1, respectively, were positively
correlated with Ki-67 LI (M-ACs vs p21WAF1/Cip1, r = 0.71,
P < 0.0001, and vs p27Kip1, r = 0.45,  P = 0.01; E-ACs vs
p21WAF1/Cip1,  r = 0.49, P = 0.005, and vs p27Kip1, r = 0.41, P = 0.02)
but not AI and MI in both M- and E-AC lesions.
RT-PCR/SBH assay
Amplicons with b-actin primers were detected with the expected
molecular weight of 446 bp in all RNAs obtained from nine
C-ACs samples, showing strong hybridization to the specific
oligonucleotide probe.
RT-PCR products amplified by primer sets of either DCC exons
6–7 or 17 were observed with molecular weights of 233 bp and
341 bp respectively. A positive correlation (r = 0.888, P = 0.0014)
between relative amounts of DCC exons 6–7 and 17 was noted.
High DCC mRNA amounts (more than the average for ACs; exons
6–7, ³ 0.7; exon 17, ³ 0.6) were observed in three (33.3%) of nine
ACs, in line with the high immunoreactivity scores (more than
average values; M-ACs, ³ 8; E-ACs, ³ 6), with the exception of
one case.
With the primer set for p21WAF1/Cip1, the expected 571 bp frag-
ment was amplified in five (55.6%) of nine ACs. Although unex-
pected fragments of approximately 350 bp were also observed,
their significance was unclear. Of the positive cases, four were
immunopositive. One case was negative for mRNA, but positive
for immunoreactivity.
Western blot assay
Western blot analysis of p21WAF1/Cip1 revealed a molecular weight
of 21 kDa in all samples investigated. An association between
Western blot findings and either mRNA or immunohistochemical
results was observed for four of five cases. For p27Kip1, a 27 kDa
band was detected in all five of the samples investigated, in line
with the immunohistochemistry. Although several lower molec-
ular weight bands were also observed, these may have been due to
protein degradation.
HPV detection
Specific amplicons using the primer set for the b-globin gene were
observed in 64 (80%) of the 80 C-AC cases. HPV-DNAs were
detected in 30 (46.9%) of these, including nine (39.1%) of 23
M-ACs, 12 (48%) of 25 E-ACs and nine (56.2%) of 16 AIS. There
was no association between HPV infection and the histological
phenotype. HPV-DNA positivity was significantly related to high
values for p27Kip1 scores (P = 0.012), AI (P = 0.008), MI (P =
0.006) and Ki-67 LI (P < 0.0001), but no association with DCC
immunoreactivity was noted.
DISCUSSION
The present immunohistochemical study demonstrated DCC
expression in normal endocervical glandular cells with
pronounced intracytoplasmic mucin accumulation, these being
considered terminally differentiated and non-replicating cells.
Previous studies revealed an association between DCC expression
and cell differentiation in several tissues. For example, DCC is
abundant in neurons of the central and peripheral nervous system,
regarded as mature and non-dividing cells (Hedrick et al, 1994). In
normal colonic epithelium, there are two major differentiated cell
types, goblet cells and enterocytes, the expression being predomi-
nant in the former (Hedrick et al, 1994). Narayanan et al (1992)
have also reported a functional role for DCC in the induction and
maintenance of the differentiated phenotype of rat PC-12 cells
derived from rat phaochromocytoma, in response to nerve growth
factor. Our results, therefore, suggest that DCC expression may
play an important role in controlling and maintaining the differen-
tiation of cervical glandular cells.
One finding of interest in this context is that levels of DCC
expression differed with the histological type of C-AC. With
tumour progression from AIS lesions, DCC expression did not
alter in M-ACs, while down-regulation was observed in E-ACs.
Hedrick et al (1994) demonstrated earlier that high levels of DCC
expression were observed in hyperplastic polyps and mucinous
carcinomas, while the expression was decreased or absent in
adenomatous polyps and adenocarcinomas of the colon, in line
with less mucin production. This suggests that there are at least
two pathways to colorectal tumorigenesis: DCC loss and failure to
differentiate toward mucin-producing cells, and a mucinous type
unassociated with alteration of DCC expression. We therefore
conclude from the present data that in C-ACs, tumour histological
phenotypes, in particular loss of the capacity to produce mucin,
may be closely associated with change in DCC expression.
Up-regulation or de-regulation of p21WAF1/Cip1 and p27Kip1 may
occur in a variety of human malignancies. For example,
p21WAF1/Cip1 expression is frequently observed in SCCs of the
larynx, in association with tumour cell differentiation (Nadal et al,
1997). In gastric carcinomas, p21WAF1/Cip1 expression is positively
correlated with tumour stage, depth of invasion and lymph node
metastasis, in line with a positive rather than an inverse association
with Ki-67 positivity (Yasui et al, 1996). Recently, Sgambato et al
(1997) demonstrated increased expression of p27Kip1 in several
cancer cell lines with rapid growth and high levels of cyclin
E-associated kinase activity, suggesting the existence of a homeo-
static feedback mechanism. Based on these reports, although it is
widely accepted that p21WAF1/Cip1 and p27Kip1 act as negative regula-
tors in normal cells (El-Deiry et al, 1993; Harper et al, 1993;
Polyak et al, 1994; Toyoshima and Hunter, 1994), they may not be
simply related to cell cycle progression in tumour cells.
In this study, significantly high values for AI, MI and Ki-67 LI
were evident in E-ACs as compared with M-ACs, along with more
pronounced expression of p21WAF1/Cip1 and p27Kip1. Considering the
significant difference in DCC expression between the two histo-
logical phenotypes, it was expected that reduced DCC expression
may contribute to rapid tumour tissue kinetics, since a close asso-
ciation between de-regulation of this gene and tumour progression
or metastasis has been reported in several human malignancies
(Kikuchi-Yanoshita et al, 1992; Enomoto et al, 1995; Kong et al,
1997; Goi et al, 1998). Our results, however, revealed that
DCC expression was not related to any cell kinetic markers or
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the association between DCC expression and tumour cell kinetics.
With regard to an association between mRNA- and protein-
based assays, a positive correlation of DCC mRNA expression
between exons 6–7 and 17 was evident in C-ACs, the amounts
being positively associated with the immunoreactivity scores.
Similar findings have also been reported for ovarian and endome-
trial carcinomas (Enomoto et al, 1995). With regard to p21WAF1/Cip1
analysis, our results indicated similar positivity for this molecule
among the three different methods in most cases. Nadal et al
(1997) also demonstrated a significant correlation of p21WAF1/Cip1
positivity between immunohistochemistry and mRNA assays in
laryngeal SCCs. In contrast, although a concordance for Western
blotting and immunohistochemistry of p27Kip1 was observed in our
series, the positivity in the former case may also include the
expression of non-epithelial cell components, in particular infil-
trating lymphocytes. Yasui et al (1997) have already reported that
discrepancies in p27Kip1 positivity between immunostaining and
Western blotting findings for gastric carcinomas might be due to
contamination of stromal cells expressing this protein.
It is widely accepted that E6 and E7 oncoproteins, produced by
HPV, are able to bind to p53 or the retinoblastoma gene product
(Rb), both well known as cell cycle-related proteins (Dyson et al,
1989; Werness et al, 1990), thereby blocking their negative effects
on progression through the cell cycle. Our results also indicated
that HPV infection is positively related to rapid tumour growth.
Alteration of DCC expression, however, may be not affected.
In conclusion, the present study demonstrated that DCC expres-
sion in C-ACs is closely associated with mucinous differentiation
but not changes in expression of p21WAF1/Cip1 and p27Kip1, apoptosis,
cell proliferation and HPV infection.
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